Dalton has the manufacturing capability for Cardiol’s clinical trial materials, scalable to support all stages of the drug development process (Phase I, II, III, and commercial).
Cardiol Therapeutics Inc. Customers
No clients on recordNo downstream customers found in our database for Cardiol Therapeutics Inc..
Cardiol Therapeutics Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CRDL-DEBT
Debt stack $84,678
90%
Market cache reports total debt of $84,678.
Cardiol Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Cardiol Therapeutics Inc..
Cardiol Therapeutics Inc. Ownership
Holder
Name
Confidence
Evidence
CRDL-OWNER-MMCAP-INTERNATIONAL-INC-SPC
MMCAP International Inc. SPC
90%
13F overlay lists MMCAP International Inc. SPC as top holder; 46 tracked holders.
Cardiol Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.